Pretty exciting news for the neurodegeneration field for a PROTAC leader like Arvinas to jump in, providing another modality tool. For a disease area as diverse as neurodegeneration, it's unlikely a single therapeutic modality will solve all the diseases, so the more diverse the modalities the merrier!
Songsong CaO
Comments